Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) price on Thursday, March 20, fall -2.33% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $15.11.
A look at the stock’s price movement, the close in the last trading session was $15.47, moving within a range at $15.07 and $15.72. The beta value (5-Year monthly) was 0.922. Turning to its 52-week performance, $30.41 and $14.23 were the 52-week high and 52-week low respectively. Overall, ARWR moved -28.32% over the past month.
Arrowhead Pharmaceuticals Inc’s market cap currently stands at around $2.07 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-09.
Wall Street analysts have also projected the company’s year-on-year revenue to grow to 304.63M, representing a 8,478.60% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ARWR is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
9 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 6 recommend ARWR as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ARWR’s current price about -11.10% and -19.00% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 35.02, while 7-day volatility ratio is 4.20% and 5.96% in the 30-day chart. Further, Arrowhead Pharmaceuticals Inc (ARWR) has a beta value of 0.92, and an average true range (ATR) of 1.00. Analysts have given the company’s stock an average 52-week price target of $26.985, forecast between a low of $24 and high of $29.97. Looking at the price targets, the low is -58.84% off current price level while to achieve the yearly target high, price needs to move -98.35%. Nonetheless, investors will most likely welcome a -78.59% jump to $26.985 which is the analysts’ median price.
If we refocus on Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), historical trading data shows that trading volumes averaged 1.52 over the past 10 days and 1.87 million over the past 3 months. The company’s latest data on shares outstanding shows there are 125.57 million shares.
The 16.64% of Arrowhead Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 70.71% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 9.2 million on 2025-02-28, giving us a short ratio of 6.88. The data shows that as of 2025-02-28 short interest in Arrowhead Pharmaceuticals Inc (ARWR) stood at 866.0 of shares outstanding, with shares short falling to 10.06 million registered in 2025-01-31. Current price change has pushed the stock -19.63% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ARWR stock continues to rise going into the next quarter.
